Table:
begin	end	state
1	16	cytoplasmic
17	36	transmembrane
37	47	non-cytoplasmic
48	71	transmembrane
72	82	cytoplasmic
83	105	transmembrane
106	140	non-cytoplasmic
141	162	transmembrane
163	181	cytoplasmic
182	205	transmembrane
206	210	non-cytoplasmic
211	238	transmembrane
239	292	cytoplasmic
293	320	transmembrane
321	325	non-cytoplasmic
326	351	transmembrane
352	356	cytoplasmic
357	378	transmembrane
379	410	non-cytoplasmic

Input:
>AO353_20105
MTAAPPTLLQRLKHTSLVTQIVIGLIVGIALALFAPEVAKSTAFIGKVFVSALKAVAPIL
VFVLVMASIANHKHGQETHIKPILFLYLLGTFAAAVVAVVASSLFPSSLVLSTHDVAISA
PGGISEVLQSLLLSVVDNPISALMNANFIGILAWAIGMGIAIRHAGETTRTVLGDLSNGV
TLIVRLVIRFAPLGIFGLVASTLATSGFGALIGYLHLLAVLLGCMLFVALVMNPAIVYWK
LRRNPYPLVLTCLRESGITAFFTRSSAANIPVNLELSKRLGLHEDTYSVSIPLGATINMA
GAAITITVLTLAAVHTLGIAVDIPTAVLLSVVAAICACGASGVAGGSLLLIPLACSLFGI
PSEIAMQVVAVGFIIGVLQDSAETALNSSTDVLFTAAACLGEDEKVQRLA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server